What are the clinical uses of cefpodoxime (cefpodoxime proxetil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Uses of Cefpodoxime Proxetil

Cefpodoxime proxetil is a third-generation oral cephalosporin indicated for mild to moderate bacterial infections, particularly respiratory tract infections, acute otitis media, uncomplicated urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. 1

FDA-Approved Indications

Respiratory Tract Infections

  • Acute otitis media caused by Streptococcus pneumoniae (excluding penicillin-resistant strains), Streptococcus pyogenes, Haemophilus influenzae (including beta-lactamase-producing strains), or Moraxella catarrhalis (including beta-lactamase-producing strains) 1

  • Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes, though cefpodoxime does not prevent rheumatic fever (only intramuscular penicillin has proven efficacy for this) 1

  • Community-acquired pneumonia caused by S. pneumoniae or H. influenzae (including beta-lactamase-producing strains) 1

  • Acute bacterial exacerbation of chronic bronchitis caused by S. pneumoniae, H. influenzae (non-beta-lactamase-producing strains only), or M. catarrhalis 1

  • Acute maxillary sinusitis caused by H. influenzae (including beta-lactamase-producing strains), S. pneumoniae, and M. catarrhalis 1

Genitourinary Infections

  • Uncomplicated urinary tract infections (cystitis) caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus 1

    • Important caveat: Cefpodoxime has lower bacterial eradication rates compared to some other approved agents for cystitis, which should be weighed when selecting therapy 1

  • Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains) 1

  • Acute, uncomplicated anorectal infections in women due to N. gonorrhoeae (including penicillinase-producing strains) 1

    • Critical limitation: Efficacy in male patients with rectal gonorrhea has not been established, and cefpodoxime is NOT effective for pharyngeal gonorrhea in either sex 1
    • CDC guidance notes: Cefpodoxime 200 mg PO does not meet minimum efficacy criteria with cure rates of 96.5% (CI = 94.8%-98.9%) for urogenital/rectal infection and only 78.9% (CI = 54.5%-94%) for pharyngeal infection 2

Skin and Soft Tissue Infections

  • Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains) or Streptococcus pyogenes 1
    • Important note: Treatment success was dose-related in clinical trials, with higher doses needed for skin infections than other indications 1
    • Abscesses require surgical drainage as clinically indicated 1

Role in Treatment Algorithms

Acute Bacterial Rhinosinusitis

Cefpodoxime proxetil is regarded as the preferred treatment for patients in whom high-dose amoxicillin or amoxicillin/clavulanate fails or is intolerable. 2

  • Cefpodoxime has activity against S. pneumoniae similar to cefuroxime axetil and cefdinir, but greater activity against H. influenzae 2
  • As a structural analog of ceftriaxone, it provides similar activity against respiratory pathogens 2
  • Major limitation: The suspension formulation has poor taste, limiting adherence in pediatric patients 2

Acute Otitis Media

  • Cefpodoxime is recommended as a second-line agent for acute otitis media in children 2
  • In comparative trials, cefpodoxime 8-10 mg/kg/day for 5-10 days was at least as effective as amoxicillin/clavulanate, cefixime, cefuroxime axetil, or cefaclor 3

Sinusitis Treatment

  • Cefpodoxime and cefdinir are suitable agents for acute bacterial sinusitis, unlike cefixime and ceftibuten which have poor activity against S. pneumoniae 2
  • Appropriate for patients requiring alternatives to amoxicillin-based regimens 2

Microbiological Spectrum

Gram-Positive Coverage

  • Good activity against streptococci, including S. pneumoniae (excluding penicillin-resistant strains) 2, 4
  • Active against S. aureus including penicillinase-producing strains 1, 4
  • No activity against enterococci 5

Gram-Negative Coverage

  • Excellent activity against H. influenzae (including beta-lactamase producers), superior to cefuroxime axetil and cefdinir 2, 4
  • Active against M. catarrhalis (including beta-lactamase producers) 1, 4
  • Good activity against Enterobacteriaceae including E. coli, Klebsiella, and Proteus 4, 5
  • Active against N. gonorrhoeae (including penicillinase-producing strains), though with limitations noted above 1, 5

Beta-Lactamase Stability

  • Stable against most commonly found plasmid-mediated beta-lactamases 4, 5

Dosing and Administration

  • Standard adult dose: 100-400 mg twice daily, depending on infection type 4, 6
  • Pediatric dose: 8-10 mg/kg/day in 1-2 divided doses 3, 7
  • Duration: Typically 5-14 days depending on infection; some experts recommend treatment until symptom-free plus 7 days for sinusitis 2
  • Food effect: Absorption is enhanced when taken with food 4

Important Clinical Considerations

Drug Interactions

  • Antacids and H2 blockers reduce peak plasma levels by 24-42% and absorption by 27-32% 1
  • Probenecid increases cefpodoxime AUC by 31% and peak levels by 20% 1
  • Monitor renal function when co-administered with nephrotoxic drugs 1

Special Populations

  • Renal impairment: Dose adjustment required; drug exposure 50% lower in hemodialysis patients 8
  • Pediatric patients: Renal clearance approximately 27% less than adults 8
  • Elderly: No dose adjustment needed in those with normal renal function 1
  • Pregnancy: Category B; use only if clearly needed 1
  • Nursing mothers: Excreted in breast milk at 0-16% of maternal serum levels at 6 hours post-dose 1

Resistance Concerns

  • Recent data (2019-2021) shows that S. pneumoniae isolates nonsusceptible to oral penicillin (MIC >0.06 mg/L) cannot reliably predict cefpodoxime susceptibility, with only 78.4% categorical agreement 9
  • Caution advised when prescribing oral cephalosporins for empiric treatment of community-acquired bacterial pneumonia in areas with penicillin-resistant pneumococci 9

Tolerability

  • Generally well tolerated with mild to moderate gastrointestinal disturbances in 4-15% of patients 4, 6
  • No pseudomembranous colitis observed in clinical trials involving over 7,000 patients 6
  • Adverse events primarily include gastrointestinal disturbances and skin rashes, consistent with other oral cephalosporins 3

References

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Research

Cefpodoxime proxetil: a comprehensive review.

International journal of antimicrobial agents, 1994

7
Research

Cefpodoxime: pharmacokinetics and therapeutic uses.

Indian journal of pediatrics, 2003

8
Research

Clinical pharmacokinetics of cefpodoxime: a systematic review.

Expert opinion on drug metabolism & toxicology, 2024

Related Questions

To which generation of cephalosporin does Cefpodoxime belong?
What is the brand name for Cefpodoxime (Cefpodoxime proxetil)?
Are there any interactions between cefpodoxime (Cefpodoxime proxetil) and doxycycline?
What is the next step in managing a child with a history of cough and cold, who was treated with cefpodoxime (a third-generation cephalosporin antibiotic) for 5 days, with initial improvement of fever, but now presents with a high fever on the fifth day of antibiotic treatment?
How does aluminium oxide interact with cefpodoxime (antibiotic) absorption?
What are the Indian Academy of Pediatrics (IAP) guidelines for using antiemetic medications in children?
What is the recommended treatment for a confirmed Group A Streptococcus pharyngitis?
How should levothyroxine be initiated and titrated for hypothyroidism, including dosing based on weight and age, and what target TSH and free T4 values should be aimed for?
What diagnosis should be considered when shoulder pain is associated with cold, temperature‑sensitive fingers on the same hand?
What fluid‑resuscitation regimen was shown to be optimal in the Waterfall trial for adults with acute pancreatitis presenting within the first 24 hours?
In a minor with a life‑threatening condition and a 50 percent chance of survival whose mother refuses all intravenous (IV) and oral medications and the child is unvaccinated, what is the next appropriate step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question